Neutral Recommendation Issued On JANX By UBS

April 15, 2026 06:15:04 am

Source: KlickAnalytics

2026-04-15 06:15:04 ET

UBS analyst issues NEUTRAL recommendation for JANX on April 15, 2026 08:58AM ET.

The previous analyst recommendation was Buy.

JANX was trading at $15.24 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 11 - Buy, 2 - Hold recommendations .

Janux Therapeutics Inc.

-0.68% G/L:

$14.64 Last:

514,387 Volume:

$14.74 Open:

May 07, 2026 04:01:00 pm

April 27, 2026 04:01:00 pm

April 16, 2026 04:01:00 pm

April 15, 2026 06:15:04 am

Market Cap $789,139,228

Float 45,531,890

Insiders Ownership 1.75%

Institutions 55

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City San Diego